Compare PII & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PII | TXG |
|---|---|---|
| Founded | 1954 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.6B |
| IPO Year | 1994 | 2019 |
| Metric | PII | TXG |
|---|---|---|
| Price | $66.13 | $30.97 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 15 |
| Target Price | ★ $62.27 | $20.25 |
| AVG Volume (30 Days) | 660.8K | ★ 2.9M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.05% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,152,000,000.00 | $245,893,000.00 |
| Revenue This Year | $1.20 | N/A |
| Revenue Next Year | $4.51 | $7.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $38.42 | $9.30 |
| 52 Week High | $75.25 | $35.65 |
| Indicator | PII | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 65.30 |
| Support Level | $62.95 | $16.11 |
| Resistance Level | $66.12 | N/A |
| Average True Range (ATR) | 2.64 | 2.19 |
| MACD | -0.26 | 0.82 |
| Stochastic Oscillator | 56.34 | 63.62 |
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).